Two main hypotheses concerning the mechanisms responsible for coronary collateral growth suggest the involvement of chemical or mechanical factors. Since we recently demonstrated that the development of the coronary collateral circulation is not closely related to the extent or duration of myocardial ischemia, we hypothesized that chronic repeated vasodilation and increased myocardial blood flow using dipyridamole would enhance collateral development in miniswine with an ameroid-occluded left circumflex coronary artery (LCx). Two days after surgical instrumentation, the animals received dipyridamole (n=9), diltiazem as an adenosine-independent vasodilator (n=8), or control vehicle (n=7) 90 minutes per day, 5 days per week for 8 weeks. At 5 and 8 weeks, transmural blood flow and systolic wall thickening were measured during infusion of dipyridamole, diltiazem, or vehicle. Transmural blood flow increased similarly in the LCx and nonoccluded regions at 30 and 60 minutes during infusion of either vasodilator. Thus, we believe that similar mechanical stimulation resulted from dipyridamole and diltiazem infusion. There was no change in blood flow during administration of the vehicle. Systolic wall thickening in the collateral-dependent region was not altered by infusion of dipyridamole, diltiazem, or vehicle. Therefore, both vasodilators increased blood flow without eliciting ischemia. After 8 weeks of repeated treatment with each pharmacological agent, at least 24 hours after the last drug infusion, near maximal physiological capacity of the coronary collateral vessels was assessed during treadmill running (=240 beats per minute). Transmural myocardial blood flow ratios, expressed as flow in the LCx divided by flow in the nonoccluded region of the left ventricle, were similar at rest for animals treated with dipyridamole (0.90±0.03), diltiazem (0.97±0.05), and control vehicle (0.89±0.02). However, collateral-dependent myocardial blood flow during exercise was greater (P<.05) in the dipyridamole-treated animals (0.78+0.04) than in either diltiazem-treated (0.63+±0.09) or vehicle-treated (0.62+±0.02) animals. LCx systolic wall thickening at rest was similar in animals treated with dipyridamole (44.4±6.3%), diltiazem (42.2+3.0%), and control vehicle (38.1±2.8%). During exercise, however, myocardial function in the collateral-dependent region was greater (P<.05) in the dipyridamole-treated (39.2+±5.2%) compared with diltiazem-treated (23.9+4.0%Yo) and vehicle-treated (26.9±2.9%Yo) animals. Our results suggest that enhanced collateral-dependent blood flow and function in dipyridamole-treated animals likely result from a direct effect of adenosine and/or from an adenosine-potentiated vascular response to repeated mechanical stress rather than a response simply related to mechanical stimulation. (Circulation Research 1993;73:503-513 Previously presented as preliminary results in abstract form (FASEB J. 1992;6:A-1506 and FASEB J. 1992;6:A-2037 
Previously, we demonstrated that development of the coronary collateral circulation are not closely related to the extent or duration of myocardial ischemia in this model. Therefore, it is possible that mechanical stimulation, rather than the process of ischemia, is a major determinant of coronary collateral development in miniswine.
Some investigators have suggested that, during gradual occlusion of a coronary artery, mechanical factors such as circumferential, radial, longitudinal, and/or shear stresses act on the walls of developing collateral vessels to enhance the growth of this vasculature. 47 All of these mechanical forces can be augmented by elevating coronary blood flow and/or the intracollateral pressure. 8 Evidence implicating mechanical factors in promoting collateral growth has been provided by observing regression of newly formed vessels when exposure to increased flow is discontinued. 9 Experimental paradigms used previously to elevate coronary flow and increase collateral vascular wall stress include repeated intermittent coronary artery occlusions,9 12 daily exercise sessions,5 and repeated administration of vasodilatory drugs. 13-l9 Although all three procedures improved collateral-dependent blood flow, several considerations must be addressed regarding the respective methodologies. First, repeated coronary artery occlusions9-12 and exercise5 dramatically increase both myocardial ischemia and vascular wall stress in the collateral-dependent myocardium. Therefore, it is difficult to determine the relative contribution of mechanical and chemical stimuli to collateral development using these experimental interventions. Second, previous studies evaluating the effects of repeated administration of vasodilatory drugs neither directly assessed the maximal blood flow capacity of the collateral vasculature during a physiological stimulus nor measured myocardial function in the collateralized region to confirm the physiological relevance of any improvements in collateral blood flow. Moreover, the possibility that increased collateral-dependent blood flow may have resulted directly from chemical factors associated with the mechanism of action of each respective vasodilator has not been adequately addressed. Consequently, although some results suggest that collateral vessel function may be enhanced after repeated exposure to vasodilatory drugs, conclusive evidence has not been provided, and any direct contributions of the drug used to elicit vasodilation have not been determined.
Most investigations concerned with enhancing coronary collateral circulation development by repeated administration of a vasodilator have used dipyridamole.13-19 Dipyridamole provides mechanical stimulation by eliciting vasodilation and elevating coronary blood flow to the native and collateral regions in our model.20 Dipyridamole works by inhibiting myocardial cell and erythrocyte uptake of adenosine, thereby increasing the interstitial concentration of this purine to cause vasodilation. 21 However, because adenosine also causes endothelial cell proliferation and migration in vitro,22,23 promotes angiogenesis in the chick chorioallantoic membrane,24 and increases myocardial capillary density in rabbits,25 a direct mitogenic effect of adenosine cannot be excluded. Therefore, like intermittent coronary artery occlusions and daily exercise, separation of the mechanical from chemical contributions to collateral development is difficult in studies using repeated administration of dipyridamole.
The purpose of the present study was to evaluate the effects of repeated mechanical stimulation by dipyridamole on development of the coronary collateral circulation and hence the adequacy of collateral perfusion during and after gradual occlusion of the LCx using an ameroid occluder. Since dipyridamole elevates interstitial concentrations of adenosine that may directly influence vascular development by a chemical mechanism, we also determined the effects of an adenosine-independent vasodilator, diltiazem, on development of the coronary collateral circulation. Diltiazem is a slow-channel calcium antagonist capable of increasing blood flow to both native and collateral-dependent myocardium. 26 We hypothesized that chronic repeated mechanical stimulation using each vasodilator increases coronary collateral growth and development such that collateral-dependent flow during treadmill exercise is greater compared with flow in a vehicle-treated control group. Furthermore, the physiological meaning of any increase in collateral-dependent blood flow would be confirmed by measuring the extent of myocardial ischemic dysfunction during treadmill running. Finally, since previous investigations suggest that long-term administration of dipyridamole may have an angiogenic effect documented as an increase in myocardial capillary density,27-30 we hypothesized that improved collateral blood flow in dipyridamole-treated animals is accompanied by enhanced growth of these microcirculatory vessels.
Materials and Methods
Surgical and experimental protocols used in this investigation were approved by the Animal Use and Care Committee at the University of California, Davis. During a 2-to 4-week period before surgery, miniswine were familiarized with human handling, transport procedures, standing, walking, and running on the motorized treadmill, and wearing a protective jacket. The pigs were housed individually in pens and fed twice daily.
Surgical Procedure
One day before surgery, the pigs were given 400 mg sulfamethoxazole and 80 mg trimethoprim orally (Tribrisson) and then were fasted overnight. Immediately before surgery, the animals were sedated with ketamine (25 mg/kg IM) and atropine (0.05 mg/kg IM) and were intubated after relaxation by mask induction with 1% to 3% halothane. During the aseptic surgical procedure, anesthesia was maintained with 1% to 2% isoflurane. A left lateral thoracotomy was performed through the fifth intercostal space, and the animals were instrumented with left atrial, pulmonary artery, and proximal descending aortic silastic catheters, a highfidelity left ventricular pressure transducer (model P 6.5, Konigsberg), and four epicardial recording electrodes. A 1.0-to 1.5-cm segment of the proximal LCx was dissected free from surrounding tissue, and a metalencased ameroid constrictor (model K-G, Ulrich, Montreal, Quebec, Canada) was placed around the vessel. The size of the constrictor (2.0-to 3.0-mm lumen) was determined at surgery so that the lumen would provide a close but nonocclusive fit around the artery. The left anterior descending coronary artery (LAD) also was dissected free, and a Doppler flow probe (2.5 mm.
Crystal Biotech, Holliston, Mass) was placed around the vessel. Sonomicrometer dimension gauges (5 MHz, 2.5 mm in diameter, J.W. Inc, San Diego, Calif) were placed across the left ventricular free wall for measurement of wall thickness (Triton Technology, San Diego, Calif). The subendocardial crystal of the pair was held at the tip of a Teflon tube (outer diameter, 1.75 mm) and advanced diagonally through the myocardium in a tract created by an 18-gauge metal cylinder. The second crystal of the pair was sewn to the epicardial surface of the heart with an attached Dacron patch. Two sets of crystals were placed 1 to 2 cm below the LCx, distal to the ameroid contrictor. These were used to assess regional myocardial function in the collateral-dependent region. Accurate placement of the sonomicrometer dimension gauges was confirmed by the presence of decreased wall thickening or frank wall thinning in the LCx region in response to a brief (10-to 20- minute from the reference blood sample. Each blood flow measurement was normalized for the weight of the myocardial tissue sample. Control blood flows in the LAD and right coronary artery (RCA) regions were similar and therefore were combined for comparison with blood flow in the LCx perfusion territory, ie, the collateral-dependent region. To account for variable flows between pigs, transmural blood flow ratios were obtained by dividing transmural flow in the collateral region by transmural flow in the control region. Blood flows in the cortex and medulla of each kidney also were determined to document adequate mixing of the microspheres. Mixing was confirmed if the difference in blood flow between the right and left kidney was <15%.
Regional Myocardial Function
Regional myocardial function was assessed with sonomicrometer dimension gauges. LCx systolic wall thickening was measured over the ejection phase of systole. The transit time of sound traveling between the ultrasonic crystals was measured as the distance between the crystals. In pigs with functional Konigsberg transducers, the ejection phase was defined as the time from the onset of rise of dP/dt to 20 milliseconds before peak negative dP/dt.33 In animals without functional Konigsberg transducers, the timing of systole was determined using the peak of the S wave and the end of the T wave of the ECG. It has been shown previously that no difference exists between dP/dt or the ST interval when calculating the systolic time interval.34 These data are expressed as percent wall thickening, calculated as end-systolic wall thickness minus end-diastolic wall thickness divided by end-diastolic wall thickness times 100. All hemodynamic and regional function calculations were determined over 5 and 10 consecutive cardiac cycles during rest and exercise, respectively. LCx systolic wall thickening measured immediately before and after each particular blood flow determination using microspheres was similar and therefore was combined.
Experimental Protocols
After surgery, the animals were separated into a group that received either dipyridamole (28 Myocardial blood flow measurements at 5 and 8 weeks before and at 30 and 60 minutes of dipyridamole, diltiazem, or vehicle infusion were similar; therefore, the data were combined (Fig 1) . Transmural blood flow increased similarly in the collateral and control regions at 30 and 60 minutes during infusion of dipyridamole and diltiazem. There was no change in blood flow to either region during infusion of the vehicle (Fig 1) . LCx systolic wall thickening was not altered from preinfusion values in all three groups (Table 1) . Systolic, diastolic, and mean arterial pressures, HR, RPP, dP/dt at DP 30, LVEDP, and LCx systolic wall thickening in each subset of animals used for blood flow determinations were not different from the values obtained using all animals (Table 1) .
Responses to Exercise
Hemodynamic variables. The increase in systolic, diastolic, and mean arterial pressures, HR, RPP, and dP/dt at DP 40 during measurement of myocardial blood flow at exercise was not different among the three groups of animals (Fig 2) . Also, blood lactate concentration increased similarly from rest to exercise among the three (Fig 3) . However, like the blood flow response during exercise, myocardial function in the collateral region was reduced less in the dipyridamole-treated compared with both the diltiazem-treated and vehicle-treated control groups. LCx systolic wall thickening was similar comparing diltiazem-treated and vehicle-treated control animals.
Capillary Density There were no differences in capillary density among the three groups or between regions within each group (Table 2) .
Discussion
The results of this study refute our original hypothesis that chronic repeated mechanical stimulation alone is capable of increasing coronary collateral growth and development. When near-maximal physiological capacity of the collateral vessels was assessed during exercise, we found that collateral-dependent blood flow was greater in dipyridamole-treated compared with diltiazem-treated and vehicle-treated animals. Therefore, we believe that increased collateral-dependent blood flow resulted from a direct effect of adenosine and/or from an adenosine-potentiated vascular response to repeated mechanical stress. Moreover, increased blood flow to the collateralized myocardium in dipyridamole-treated animals was physiologically meaningful, since exerciseinduced ischemic dysfunction was reduced. Finally, we observed no alterations in transmural myocardial capillary density among the three groups of miniswine. Thus, we believe that increased collateral flow in the dipyridamole-treated animals resulted from remodeling of preexisting anastomotic channels rather than from formation of new vessels, since our index of angiogen- In addition, theoretical analysis predicts that, after ischemia has altered the cellular structure of a vessel, circumferential, radial, longitudinal, and shear stresses are mechanical forces that may be capable of eliciting cellular proliferation. 4 Experimental paradigms previously used to elevate coronary flow and increase collateral vascular wall stress include repeated intermittent coronary artery occlusions,9 12 daily exercise sessions,5 and repeated administration of vasodilatory drugs.13-19 Although these procedures improved collateral-dependent blood flow, the methodologies used in each study involve a combination of potential angiogenic stimuli. First, repeated occlusion of a coronary artery elicits pressure differences between the occluded and nonoccluded regions of the myocardium, resulting in maximal vasodilation and severe ischemia in the collateral-dependent region. These increased pressure gradients augment blood flow through preformed collateral channels during each occlusion and contribute to increased blood flow velocity and vessel wall stress in the collateraldependent region immediately after each occlusion.9-12 Second, the acute response to exercise involves increases in blood flow velocity and intravascular pressure in the native and collateral circulation and severe myocardial ischemia in the collateral-dependent region.5 Therefore, separating the contribution of mechanical forces and factors associated with the process of ischemia to coronary collateral growth and development is difficult in studies using repeated coronary occlusions and long-term exercise. Third, previous studies using repeated administration of vasodilators to enhance collateral vessel development did not assess the possible direct mitogenic effects of the pharmacological agent used. For instance, dipyridamole increases the concentration of adenosine in the coronary vasculature. 21 Since evidence exists demonstrating that, in addition to its vasodilator properties, adenosine may be angiogenic and potentiate the vascular response to other mitogenic stimuli,222425 the contribution of this factor to collateral-dependent flow development may be important. Moreover, a role for adenosine in contributing to increased collateral-dependent blood flow development observed after repeated exercise sessions or coronary occlusions cannot be discounted, since these interventions increase adenosine concentrations as well.49 Therefore, like intermittent coronary artery occlusions and daily exercise, separating mechanical from chemical contributions to collateral development is difficult in studies using repeated administration of substances such as dipyridamole. Additionally, previous studies using repeated administration of a vasodilator did not directly measure maximal blood flow capacity of the collateral vasculature during physiological stimulation and did not measure myocardial function in the collateralized region to confirm the physiological relevance of any improvements in collateral blood flow.13 -19 Therefore, ambiguity exists regarding the ability of substances such as dipyridamole to elicit increases in coronary collateral blood flow that are physiologically meaningful.
In light of these considerations, we examined the contribution of repeated mechanical stimulation to collateral growth and development using an adenosinedependent (ie, dipyridamole) and an adenosine-inde-pendent (ie, diltiazem) vasodilator. We felt that the acute response to vasodilation would enhance both circumferential and longitudinal vessel wall stress since, despite reduced intraluminal pressure, these stresses are augmented because vessel radius is increased.4 Furthermore, shear stress is increased acutely by dipyridamole and diltiazem because blood flow velocity is elevated through dilated collateral channels. We chose to use dipyridamole, since data from previous investigations, although inconclusive, suggested that it could promote collateral flow development. Diltiazem was chosen as our adenosine-independent vasodilator since preliminary data from our laboratory indicated that blood flow elevations to native and collateral-dependent myocardium were similar to those obtained using dipyridamole. By measuring LCx systolic wall thickening at least three times per week in each animal, we also verified that regional function was not compromised and hence ischemia did not occur during administration of either vasodilator.
The miniswine was selected as an experimental model because the anatomy and physiology of its coronary collateral circulation is similar to that of humans. 54 Previously,6 however, we observed that collateral development can occur without increases in transmural capillary density. These results suggested that collateral development occurred from growth and maturation of preformed anastomotic channels rather than from growth of new vessels. In light of evidence suggesting that adenosine is an angiogenic stimulus,822-25,54,55 we originally predicted that chronic dipyridamole administration would stimulate new capillary growth. Results from the present study indicate that regional and transmural myocardial capillary density were unaltered in animals receiving dipyridamole. It could be argued that capillary density may have been stimulated in the diltiazem-treated and vehicle-treated animals, thus contributing to the fact that no differences were observed. We feel this to be unlikely, however, since capillary density in these two groups was identical to a control group of animals used in a previous investigation. 6 The discrepancy between our findings and those of others within 3 to 4 weeks after placement of an ameroid occluder.6,37 Five weeks, therefore, represents the initial period of stabilization after collateral development. Eight weeks represents a period of stable collateral flow, during which we assessed the response of large and small vessels to chronic repeated infusion of a vasodilator. Our data suggest that angiogenesis did not occur. However, growth of larger vessels appeared to occur early (ie, before 5 weeks) during collateral development but not later (ie, 5 to 8 weeks), when collateral blood flow of unstimulated vessels remains stable.563
A possible explanation for the finding that dipyridamole-treated animals had greater collateral-dependent blood flow during exercise could be that dipyridamole exerted greater mechanical stimulation than did diltiazem. However, we measured transmural myocardial blood flow in the native and collateral circulations after 5 and 8 weeks during infusion of these pharmacological agents. Results confirmed that both vasodilators elicited similar increases in transmural blood flow. LAD blood flow velocity, and mechanical stimulation. Since verification of the acute blood flow responses to dipyridamole, diltiazem, and vehicle were performed in a subset of animals, a potential criticism is that transmural blood flow ratios and LCx systolic wall thickening observed during exercise may be different compared with those for the entire group of experimental animals. However, transmural blood flow ratios and regional myocardial function at rest and during exercise in this subset of animals were similar to those reported for all animals in Fig 3. An additional concern could be that vasodilation preferentially occurred in the native coronary circulation, causing a coronary steal from the collateralized region, thereby eliciting myocardial ischemia that contributed to collateral development in the dipyridamoletreated animals. We feel this possibility to be unlikely since blood flow increased to the same extent in the control and collateral-dependent regions and since LCx systolic wall thickening was not attenuated throughout administration of either vasodilator. Moreover, collateral-dependent blood flow and myocardial function were not enhanced in the diltiazem-treated animals despite the fact that the extent and duration of vasodilation was similar to the dipyridamole-treated animals.
Dipyridamole infusion is capable of stimulating prostacyclin production in the forearm vasculature of humans.9 In addition, PGE2 elicits angiogenesis in the chick chorioallantoic membrane.60 Therefore, concern could be raised that dipyridamole administration enhanced collateral development through a PG-mediated mechanism. To investigate this possibility, blood samples were obtained from the coronary sinus before and during dipyridamole infusion for the measurement of 6-keto-PGFi,, the stable metabolite of prostacyclin, and PGE2. Since we observed no increase in either PG, we feel that any contribution from these sources to collateral development is unlikely.
Finally, it could be argued that development of collateral-dependent blood flow was inhibited by chronic administration of diltiazem and vehicle rather than stimulated by chronic dipyridamole treatment. This explanation seems unlikely, however, since transmural blood flow ratios obtained during exercise at 8 vehicle-treated (control) animals (0.62+0.02) were similar to those reported in a control group of animals used previously (0.59±+0.06).6
In summary, data presented here do not confirm our original hypothesis that repeated mechanical stimulation alone enhances coronary collateral development in our model. When near-maximal capacity of the collateral vessels was assessed during exercise, we found that blood flow and regional myocardial function were greater in dipyridamole-treated compared with diltiazem-treated and vehicle-treated animals. In addition, we observed no alterations in transmural myocardial capillary density among the three groups of miniswine. Therefore, we believe that increased collateral-dependent blood flow resulted from a direct effect of adenosine and/or from an adenosine-potentiated vascular response to repeated mechanical stress. Moreover, we feel that increased collateral flow in the dipyridamole-treated animals resulted from remodeling of preexisting anastomotic channels rather than from formation of new vessels, since our index of angiogenesis (ie, capillary density) was not altered among the experimental groups.
